FCF Biotech
Public Equity Monitor

The FCF Biotech Public Equity Monitor comprises of listed small- and midcap companies, headquartered in Europe, from the biotechnology, pharma and med-tech sectors. The Monitor is a derivative of the FCF Valuation Monitor, adjusted to valuation and performance metrics suited for the Life Sciences sector.

FCF Biotech Public Equity Monitor
Share Price Potential...
Performance and Valuation..
Break-Even Analysis...
Liquidity Analysis...
Shareholder Analysis...
Previous
Next
FCF Biotech Public Equity Monitor
Share Price Potential...
Performance and Valuation..
Break-Even Analysis...
Liquidity Analysis...
Shareholder Analysis...
Previous
Next

LIFE SCIENCES RESEARCH SERIES

We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our FCF Life Sciences Research Series focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:

Licensing Research

Recent licensing trends of European Biotech companies in China
Upcoming
Recent licensing trends of European Biotech companies in China
Upcoming

Biotech Licensing Monitor – China
-Upcoming-
Recent licensing trends of European Biotech companies in China

Other Life Sciences Researches

Recent valuations of listed MedTech companies
Upcoming
MedTech Public Equity Monitor

Life Sciences IPO Report
Recent IPO trends in the Life Sciences sector

Biotech Public Equity Monitor
Recent valuations of listed European Life Sciences companies

MedTech Public Equity Monitor
-Upcoming-
Recent valuations of listed MedTech companies

NEWS & PRESS

Scroll Up